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Abstract
Innate immune activation via IL-1R or Toll-like receptors (TLR) contibutes to acute kidney injury but its role in tissue
remodeling during chronic kidney disease is unclear. SIGIRR is an inhibitor of TLR-induced cytokine and chemokine
expression in intrarenal immune cells, therefore, we hypothesized that Sigirr-deficiency would aggravate postobstructive
renal fibrosis. The expression of TLRs as well as endogenous TLR agonists increased within six days after UUO in obstructed
compared to unobstructed kidneys while SIGIRR itself was downregulated by day 10. However, lack of SIGIRR did not affect
the intrarenal mRNA expression of proinflammatory and profibrotic mediators as well as the numbers of intrarenal
macrophages and T cells or morphometric markers of tubular atrophy and interstitial fibrosis. Because SIGIRR is known to
block TLR/IL-1R signaling at the level of the intracellular adaptor molecule MyD88 UUO experiments were also performed in
mice deficient for either MyD88, TLR2 or TLR9. After UUO there was no significant change of tubular interstitial damage and
interstitial fibrosis in neither of these mice compared to wildtype counterparts. Additional in-vitro studies with CD90+ renal
fibroblasts revealed that TLR agonists induce the expression of IL-6 and MCP-1/CCL2 but not of TGF-b, collagen-1a or
smooth muscle actin. Together, postobstructive renal interstitial fibrosis and tubular atrophy develop independent of
SIGIRR, TLR2, TLR9, and MyD88. These data argue against a significant role of these molecules in renal fibrosis.
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Introduction
Chronic kidney disease is usually associated with diffuse
remodeling of the tubulointerstitial compartment. Tubular
atrophy and interstitial fibrosis represent a common terminal
pathway of various types of kidney diseases involving numerous
pathomechanisms and effector elements [1] such as loss of
peritubular vasculature and ischemia [2], epithelial-mesenchymal
transition [3], recruitment of circulating fibrogenic progenitor cells
[4], the release of growth factors and proapoptotic molecules [5],
and interstitial inflammation driven by chemokine-mediated
leukocyte recruitment [6]. The factors that orchestrate the onset,
resolution or progression of renal fibrosis remain unclear.
Generally, tissue remodeling is the result of a danger response
[7]. All cell types can recognize toxic, metabolic, infectious,
mechanic or osmotic types of danger and elicit primary signals that
trigger defense mechanisms and that alert other cells. For example,
pathogens trigger the expression of proinflammatory cytokines and
chemokines via the activation of Toll-like receptors (TLR) by
pathogen-associated molecular patterns (PAMP) like LPS, lipo-
peptides or bacterial DNA [8]. It has now become clear that the
TLR-dependent innate immune response is essential in mediating
host defense to infection and to infection-related inflammation and
tissue remodeling [7,8]. Interestingly, TLRs can trigger inflam-
mation and tissue remodeling also in the absence of pathogens or
PAMPs [9]. Dying cells were found to elicit identical immune
activation by the release of endogenous ‘danger-associated
molecular patterns’ (DAMP) that have immunostimulatory effects
and act as endogenous immune adjuvants [10]. As such TLRs
seem to functionally act as universal danger recognition receptors
that alert the immune system to tissue damage independent of the
type of injury [10]. This universal mechanism also applies to
kidney diseases [11]. For example, postischemic renal inflamma-
tion and tubular damage are significantly reduced in mice
deficient for TLR2, TLR4 or MyD88, the main adaptor molecule
for these TLRs [12,13,14,15,16]. Data from other acute kidney
injury models further support the role of TLRs in renal danger
signaling [17,18]. Does this concept also apply to tissue remodeling
in chronic kidney disease? Only few studies have yet addressed this
issue experimentally. Wang, et al. reported that tubulointerstitial
disease was reduced in wildtype kidneys transplanted into TLR2-,
TLR4-, TLR2/4-, MyD88-, and TRIF-deficient recipients [19].
These data document a role for TLRs in alloimmunity against a
renal graft but not necessarily about the role of TLR signaling
inside the donor kidney. The unilateral ureteral obstruction
(UUO) model is often used in the context of renal fibrosis [20,21]
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19204and data from TLR2– or TLR4-deficient mice propose that TLR
signaling contributes to postobstructive renal inflammation,
tubular atrophy, and interstitial fibrosis [22,23].
Negative regulators of TLR signaling limit innate immune
activation and thereby prevent inappropriate immunopathology
[24]. For example, the TIR8 gene encodes for single immuno-
globulin IL-1-related receptor (SIGIRR) [25]. This TLR/IL-1R
family member suppresses LPS or IL-1-induced activation of NF-
kB, a process that protects from immunity-mediated tissue damage
upon pathogen challenge or dextran-induced damage of the
intestinal epithelium [25]. Inside the kidney, SIGIRR is expressed
by tubular epithelial cells, dendritic cells, and macrophages but
functional activity of SIGIRR is limited to renal immune cells only
[26]. SIGIRR was also shown to suppress inflammation and tissue
remodeling in intrarenal immune cells during urinary tract
infection [26], lupus nephritis [27,28], and postischemic acute
renal failure [29,30].
We therefore hypothesized that SIGIRR would also suppress
postobstructive tubular atrophy and renal fibrosis by inhibiting the
TLR-dependent activation of renal inflammation. We addressed
this hypothesis experimentally by inducing UUO in Sigirr(Tir8)-
deficient mice. In addition, we performed UUO in mice deficient
for either TLR2, TLR9 or MyD88.
Results
SIGIRR suppresses the activation of intrarenal immune
cells
SIGIRR is known to suppress TLR signaling in antigen-
presenting cells [25]. Therefore, we first determined its potential to
suppress LPS-induced production of proinflammatory and profi-
brotic mediators in renal immune and non-immune cells. We
prepared single cell suspensions from kidneys of wildtype and
Sigirr-deficient mice and separated CD45 positive immune cells
and CD45 negative non-immune cells by magnetic bead isolation
before all cells were incubated with either medium or medium plus
LPS. Lack of SIGIRR increased the TLR agonist-induced mRNA
expression of IL-6, RANTES/CCL5, MCP-1/CCL2, TNFa, and
TGF-b but only in CD45 positive cells (Figure 1). Thus, SIGIRR
suppresses the TLR-induced expression of proinflammatory
cytokines in renal immune cells but not in renal parenchymal cells.
Renal expression of TLR and their endogenous agonists
after UUO
Renal immune and non-immune cells express TLRs [31] but
how are TLRs and their potential endogenous agonists regulated
in the postobstructive kidney? To address this question we
performed UUO in 6 weeks old C57BL/6 mice, harvested
kidneys at 2, 6 or 10 days after surgery, and performed real-time
RT-PCR to quantify mRNA expression in obstructed and sham-
operated kidneys. The renal mRNA levels of fibrosis-related genes
such as MMP7 or CTGF were induced in obstructed but not in
sham-operated kidneys from as early as 2 days after surgery and
their expression level increased over time along with the known
progressive nature of interstitial fibrosis after UUO (Figure 2). A
similar mRNA expression pattern was observed for biglycan, a
matrix molecule that can serve as a DAMP by ligating TLR2 and
TLR4 (Figure 2). By contrast, the DAMP HMGB1 was not
regulated by UUO whereas the DAMP-producing enzyme
hyaloronic acid synthetase (HAS)2 was induced in obstructed
and sham-operated kidneys early post-surgery (Figure 2). The
HAS2 induction declined over time in sham-operated but not in
obstructed kidneys. Next we quantified the mRNA expression of
TLR2, 23, 24, 27, and 29. TLR2 was the only receptor already
induced in obstructed kidneys at day 2 after surgery (Figure 2). All
TLRs were induced only in obstructed kidneys from day 6 after
surgery but the expression levels did not further increase at day 10.
Together, surgery increases renal DAMP mRNA expression and
UUO further increases the expression levels for biglycan and
HAS2. TLRs are generally induced in obstructed kidneys but the
expression level dynamics do not correlate with those of genes that
are known to mirror the progression of interstitial fibrosis.
SIGIRR is expressed in the kidney during UUO
As UUO induced the intrarenal expression of many genes
related to TLR signaling we questioned whether UUO would also
induce renal SIGIRR expression. However, renal mRNA
expression of SIGIRR rather declined in UUO versus unobstruct-
ed kidneys, especially 10 days after UUO (Figure 3A). Western
blot confirmed this downmodulation of renal SIGIRR expression
in UUO kidneys 10 days after surgery (Figure 3B). Thus, the
intrarenal induction of TLR expression after UUO is associated
with a downregulation of SIGIRR.
Lack of SIGIRR does not affect the renal expression of
proinflammatory and profibrotic mediators during UUO
As SIGIRR suppresses the production of proinflammatory
mediators in intrarenal immune cells upon exposure to TLR
agonists, we expected higher cytokine expression levels in UUO
kidneys of Sigirr-deficient mice. But when we compared renal
mRNA expression levels of MCP-1/CCL2 and RANTES/CCL5
in obstructed and sham-operated kidneys at 2, 6 or 10 days after
surgery we found their expression levels to be independent of the
SIGIRR genotype (Figure 4). The same was found for the
profibrotic cytokines TGF-b and CTGF or for collagen-1a,
vimentin, Acta2/SMA (Figure 4). The mRNA expression of E-
cadherin, Hsp47 and MMP7 was also independent of the
genotype. Together, lack of SIGIRR does not affect the intrarenal
mRNA expression of the proinflammatory chemokines, profibrotic
mediators, or markers of renal fibrosis after UUO.
Lack of SIGIRR does not affect macrophage recruitment
or myofibroblasts in UUO
The intrarenal expression of proinflammatory chemokines
should correspond to the number of infiltrating leukocytes into
the postobstructive kidney. Immunostaining for F4/80 positive
macrophages revealed no significant difference in the F4/80
positive areas between UUO (or sham) kidneys from Sigirr-
deficient and wildtype mice (8.060.7% versus 7.660.7%,
Figure 5). Intrarenal macrophages and the expression of
profibrotic mediators usually predict the number of myofibroblast
after UUO. We quantified intrarenal myofibroblasts by immuno-
staining for smooth muscle actin (SMA) but could again not detect
any difference in the SMA positive areas between UUO (or sham)
kidneys from Sigirr-deficient and wildtype mice (21.762.1% versus
22.061.8%, Figure 5). Thus, lack of SIGIRR does not affect the
numbers of intrarenal macrophages and myofibroblasts in
postobstructive kidneys.
Lack of SIGIRR does not affect tubular atrophy and
interstitial fibrosis during UUO
Intrarenal macrophages and myofibroblasts contribute to
progressive tissue remodeling in the postobstructive kidney. We
used morphometry of silver-stained renal sections to quantify
tubular atrophy, tubular dilatation, and interstitial volume as
markers of obstructive tubulointerstitial disease in both strains of
mice. None of these parameters was differed significantly between
SIGIRR in Renal Fibrosis
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(Figure 6). Thus, lack of SIGIRR does neither affect intrarenal
inflammation, macrophage or myofibroblast accumulation or
tissue remodeling after UUO.
Postobstructive kidney remodeling develops
independent of MyD88, Tlr2, and Tlr9
SIGIRR is known to suppress innate immunity via interaction
with the intracellular adaptor molecule MyD88 which blocks the
activation of multiple TLRs and IL-1Rs [32]. The lacking
phenotype of Sigirr-deficient mice suggests that innate immune
activation via MyD88 does not contribute or is redundant in the
UUO model. To test this hypothesis we also induced UUO in
mice deficient for MyD88, TLR2, and TLR9, and evaluated
tubulointerstitial remodeling at 10 days after UUO compared to a
separate set of wildtype controls. Morphometry of silver and
Masson Trichrome stains did not reveal any significant differences
for the indices of tubular damage, tubular lumen, interstitial
volume (Silver), and interstitial fibrosis (Masson Trichrome) of any
of the aforementioned mouse strains as compared to wildtype mice
(Figure 7). Thus, neither SIGIRR, MyD88, TLR2 nor TLR9
Figure 1. SIGIRR and the activation of renal immune and non-immune cells. Renal cell suspensions from wildtype and Sigirr-deficient mice
were separated into CD45 positive immune cells and CD45 negative non-immune cells by magnetic bead isolation as described in methods. Cells
were stimulated with 1 mg/ml Pam3Cys lipopeptide (TLR2), LPS (TLR4) or CpG-DNA (TLR9) and mRNA expression levels were determined by real-time
RT-PCR for several genes after 6 hours of stimulation as indicated. Results were related to the respective 18S rRNA expression and are expressed as
means 6 SD. * p,0.05 versus wildtype.
doi:10.1371/journal.pone.0019204.g001
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10 days after UUO.
TLR activation does not trigger TGF-b, SMA and
collagen-1a production in renal fibroblasts
The capacity of TLRs to activate renal immune and non-
immune cells for the secretion of proinflammatory cytokines is well
described [31]. It is, however, yet unknown whether TLR
signaling modulates the secretion of profibrotic mediators. To
address this issue we isolated CD90+ renal fibroblasts from 6 week
old mice and stimulated them with agonists for TLR2 (Pam3Cys
lipopetide), TLR4 (LPS), TLR9 (CpG-DNA) and with TNF-a.
The activation of TLR2 and TLR4 activated renal fibroblasts to
induce MCP-1/CCL2 and IL-6 mRNA within 24 hours while
TGF-b, collagen-1a, and smooth muscle actin remained at
baseline levels (Figure 8A). The CpG-DNA had no significant
effect on MCP-1 mRNA expression because renal fibroblasts do
not express TLR9. The same pattern was found at the protein
level by MCP-1/CCL2 and TGF-b ELISA when we analysed
renal fibroblast culture supernatants after 48 hours of stimulations
(Figure 8B). Thus, TLR activation in renal fibroblasts triggers
proinflammatory mediators like MCP-1/CCL2 and IL-6 but does
not induce the production of profibrotic molecules like TGF-ß,
collagen-1a, and smooth muscle actin in renal fibroblasts.
Figure 2. TLR and TLR agonist mRNA expression after UUO. Wildtype mice underwent surgery and UUO kidneys (black bars) or contralateral
kidneys (Co, grey bars) were harvested at different time points after surgery as indicated. mRNA expression levels were determined by real-time RT-
PCR and related to the respective 18S rRNA expression. Data are expressed as means 6 SD. * p,0.05 versus wildtype of the same time point,
# p,0.05 versus time point day 2.
doi:10.1371/journal.pone.0019204.g002
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We had hypothesized that SIGIRR would suppress postob-
structive tubular atrophy and renal fibrosis by inhibiting the TLR-
dependent activation of renal inflammation and fibrosis. Our
results are in contrast to this hypothesis and rather document that
UUO-induced kidney remodeling is independent of the Sigirr
genotype as well as of TLR2, TLR9, and MyD88 compared to
wildtype C57BL/6 mice.
Figure 3. Renal SIGIRR expression after UUO. A. Wildtype mice underwent surgery and UUO kidneys (black bars) or contralateral kidneys (Co,
grey bars) were harvested at different time points after surgery as indicated. mRNA expression levels were determined by real-time RT-PCR and
related to the respective 18S rRNA expression. Data are expressed as means 6 SD. * p,0.05 versus wildtype of the same time point, # p,0.05 versus
time point day 2. B. Protein samples were obtained from the same kidney for SIGIRR Western blot. A kidney from Sigirr-deficient mouse served as
negative control for the specificity of the SIGIRR antibody. b-tubulin staining is given as a loading control. The quantitative analysis is shown below.
*p,0.05 versus contralateral kidney.
doi:10.1371/journal.pone.0019204.g003
SIGIRR in Renal Fibrosis
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e19204Lack of SIGIRR was recently shown to aggravate a number of
different kidney disease models including lupus nephritis [27,28],
renal infection [26], and postischemic acute renal failure [29,30].
In lupus nephritis lack of SIGIRR mainly affected the systemic
autoimmune disease but in renal infection or postischemic renal
failure intrarenal dendritic cells or macrophages were shown to be
increasingly activated in Sigirr-deficient mice [26,29,30]. Increased
activation of antigen-presenting cells increased intrarenal cytokine
signaling, leukocyte recruitment, and renal injury [26,30]. The
suppressive role of SIGIRR on immunopathology in these models
could be refered to the role of TLR signaling during immune
recognition of LPS from uropathogenic E. coli [26] or DAMP
release during ischemic cell necrosis [30], two well known triggers
of TLR signaling [8,10]. In fact, the role of TLR4 signaling in
intrarenal dendritic cells was documented to contribute to the
immunopathology infective pyelonephritis in mice [33]. Lack of
SIGIRR’s inhibitory effect of TLR4 signaling aggravates inflam-
mation and immunopathology in renal infection [26]. Several
studies document a similar role for TLR2, TLR4, and MyD88 in
postischemic acute renal failure of C57BL/6 mice [12,13,14].
Figure 4. Renal mRNA expression in wildtype and Sigirr-deficient kidneys after after UUO. Wildtype (black bars) and Sigirr-deficient mice
(white bars) underwent UUO and kidneys were harvested at different time points after surgery as indicated. mRNA expression levels were determined
by real-time RT-PCR and related to the respective 18S rRNA expression. Data are expressed as means 6 SD. # p,0.05 versus wildtype of the same
time point, * p,0.05 versus time point day 2.
doi:10.1371/journal.pone.0019204.g004
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pathway aggravates postischemic acute renal failure [30].
Our finding that lack of SIGIRR does not modulate UUO-
induced renal pathology question a functional contribution of
TLR signaling in UUO. Leemans, et al. reported results from
UUO experiments in Tlr2-deficient mice of the C57BL/6
background [22]. Tubular injury and interstitial fibrosis remained
unaffected by the Tlr2 genotype which is consistent with our
findings as well as with our results obtained with Myd88-deficient
mice. The latter data are confirmative because MyD88 is the only
signaling adaptor for TLR2 [31]. MyD88 is also the only signaling
adaptor for the CpG-DNA receptor TLR9, hence, Tlr9-deficient
mice also had no phenotype in the UUO model. All these data are
consistent with the lack of phenotype in Sigirr-deficient mice
because SIGIRR suppresses TLR signaling by inhibiting TIR
domains interactions between the TLRs and MyD88 [32]. We
therefore conclude that SIGIRR is redundant in UUO-induced
renal fibrosis because TLR2-, TLR9- and MyD88 signaling do not
significantly contribute to this model. Two other studies have
documented that Tlr4-deficient mice develop less renal fibrosis after
UUO [23,34]. These data are not necessarily conflicting to our
results because MyD88 is not the only signaling adaptor for TLR4
[31].TLR4doesalsoinduceinflammationviaitsadaptorTRIFand
the role of SIGIRR on TRIF signaling is not yet fully characterized
[25]. However, it is of note that we (data not shown) and others [35]
were unable to reproduce the strong UUO phenotype of Tlr4-
deficient mice reported by Campbell, et al. [23] or not even their
weak UUO phenotype reported by Pulskens, et al. [34]. Impaired
TRIF rather than MyD88 signaling might account for less renal
fibrosis in Tlr4-deficient mice [23]. In fact, TRIF signaling was
Figure 5. Macrophages and myofibroblasts in the postobstructive kidney. Cortical renal sections were either stained with F4/80 or SMA.
Images illustrate representative sections of UUO and sham-operated kidneys 10 days after UUO in mice of the respective group as indicated (original
magnification 2006).
doi:10.1371/journal.pone.0019204.g005
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[36] but contributed to chronic allograft nephropathy in mice [19].
In summary, tubular atrophy and interstitial fibrosis after UUO
develop independent of the TLR signaling inhibitor SIGIRR
mainly because TLR2, TLR9, and their essential adaptor
molecule and SIGIRR’s interaction target MyD88 do not
significantly contribute to the postobstructive renal inflammation
and tissue remodeling. Obviously, TLR-MyD88 signaling, known
to mediate acute kidney injuries, is not significantly involved in
postobstructive progressive renal fibrosis.
Materials and Methods
Animal studies
Sigirr-deficient mice were generated and backcrossed into the
C57BL/6 background for 10 generations as described [37]. Mice
Figure 6. SIGIRR and morphometric analysis of tubulointerstitial pathology after UUO. Cortical renal sections were stained with silver.
Images illustrate representative sections of UUO and sham-operated kidneys 10 days after UUO in mice of the respective group as indicated (original
magnification 2006). The indices for interstitial volume, tubular damage, and tubular lumen were determined in UUO kidneys from wildtype (black
bars) and Sigirr-deficient mice (white bars) by quantitative morphometry as decribed in the methods section. Values represent means 6 SD from 10
high power fields of UUO kidneys from 10 mice in each group.
doi:10.1371/journal.pone.0019204.g006
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Dr. Shizuo Akira, Osaka, Japan as described [38,39,40] and
backcrossed to C57BL/6 for at least 6 generations. We used
C57BL/6 mice from Charles River (Sulzfeld, Germany) for
backcrossing and as wildtype controls. All mice were housed in
groups of 4 mice in filter top cages with a 12 hour dark/light cycle
and unlimited access to food and water. Cages, bedding, nestlets,
food and water were sterilized by autoclaving before use. UUO
Figure 7. TLRs and morphometric analysis of tissue remodeling after UUO. A: Cortical renal sections were stained with silver. Images
illustrate representative sections of UUO kidneys 10 days after UUO in mice of the respective group as indicated (original magnification 2006). B: The
indices for tubular cell damage, tubular dilatation, interstitial volume were determined by quantitative morphometry in obstructed kidneys at 10 days
as described in methods. C: Interstitial fibrosis was quantified by digital morphometry on Masson Trichrom-stained sections as percentage of entire
high power field. Values represent means 6 SD from 10–15 high power fields.
doi:10.1371/journal.pone.0019204.g007
SIGIRR in Renal Fibrosis
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and gene-deficient mice as previously described [41]. Contralat-
eral kidneys served as intraindividual control. All experimental
procedures were performed according to the German animal care
and ethics legislation and had been approved by the local
government authorities (Regierung von Oberbayern, Az 55.2-1-
54-2531-34-03 and 11-10).
Morphological evaluation
Tissue sections from the obstructed and the contralateral
kidneys of each mouse were fixed in 10% formalin in PBS and
embedded in paraffin. 2 mm sections were stained with periodic
acid-Schiff reagent and silver as standard procedures. To count
interstitial cells 15 high power fields (hpf, 4006) were analyzed by
a blinded observer. Positive cells were counted per high power
Figure 8. TLR-induced expression of cytokines and profibrotic mediators in renal fibroblasts. CD90+ fibroblasts were prepared from
mice and cultured as described in methods. The cells were stimulated with 1 ug/ml of either Pam3Cys lipopeptide (TLR2 agonist), LPS (TLR4 agonist),
CpG-DNA (TLR9 agonist) or 5 ng/ml TNFa. A: After 24 hours of stimulation cell mRNA was isolated and quantified by real-time PCR and refered to the
respective 18S rRNA level. Data represent means 6 SEM from three independent experiments. * p,0.05 versus medium. B: Renal fibroblasts were
stimulated as before and cell culture supernatants were obtained after 24 (white bars) and 48 hours of stimulation (black bars). MCP-1 and TGF-b
levels were measured by ELISA. Data represent means 6 SEM from three independent experiments. * p,0.05 versus medium.
doi:10.1371/journal.pone.0019204.g008
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tubulointerstitial was performed as previously described [42]. In
brief, the interstitial volume index was determined by superposing
a grid containing 100 (10610) sampling points on photographs of
10 non-overlapping cortical fields of silver stained tissue (4006)o f
each kidney. The number of points overlying interstitial space
were counted. The indices of tubular cell damage and tubular
dilatation were assessed accordingly. Interstitial fibrosis was
quantified by digital morphometry on Masson Trichrome-stained
paraffin-embedded sections as described [43]. The following
primary antibodies were used: rat anti-F4/80 (Serotec, Oxford,
UK, 1:50), mouse-anti-smooth muscle actin (Dako, Glostrup,
Denmark, 1:100).
In vitro studies
For CD45+ and CD45- renal cells isolation kidneys were
minced, passed through 70 and 30 mm cell strainers, and positive
selection of CD45+ cells was performed by magnetic cell sorting
technique (MACS separation, Miltenyi, Bergisch-Gladbach,
Germany) as previously described [44]. Cells were incubated with
the magnetic beads in 500 ml buffer containing phosphate-buffered
saline (PBS) pH 7.2, 0.5% BSA and 2 mM EDTA at 4uC for
15 min. The cells were washed by adding 1–2 ml of buffer and
centrifuged twice. Pellets containing labeled cells were resus-
pended in buffer and passed through MACS LS column. After
separation cells were found to be .95% purity by FACS analysis.
The negative selected cells (flow through) were used as CD45- cell
Table 1. Primers used for real-time RT-PCR.
Gene Accession no. Sequence
Sigirr NM023059 forward primer: 59- AGAGGTCCCAGAAGAGCCAT -39
reverse primer: 59- AAGCAACTTCTCTGCCAAGG - 39
Ccl2/Mcp-1 NM011333 forward primer: 59- CCTGCTGTTCACAGTTGCC -39
reverse primer: 59- ATTGGGATCATCTTGCTGGT-39
Acta2/a-Sma NM_007392 forward primer: 59- ACTGGGACGACATGGAAAAG -39
reverse primer: 59- GTTCAGTGGTGCCTCTGTCA - 39
Col1a1 NM_007742 forward primer: 59- ACATGTTCAGCTTTGTGGACC -39
reverse primer: 59- TAGGCCATTGTGTATGCAGC - 39
Tgf-b1 NM_011577 forward primer: 59- GGAGAGCCCTGGATACCAAC -39
reverse primer: 59- CAACCCAGGTCCTTCCTAAA -39
Il-6 NM031168 forward primer: 59- TGATGCACTTGCAGAAAACA -39
reverse primer: 59- ACCAGAGGAAATTTTCAATAGGC - 39
Tnf-a NM011609 forward primer: 59- CCACCACGCTCTTCTGTCTAC -39
reverse primer: 59- AGGGTCTGGGCCATAGAACT -39
Ccl5/Rantes NM_013653 forward primer: 59- CCACTTCTTCTCTGGGTTGG-39
reverse primer: 59- GTGCCCACGTCAAGGAGTAT-39
Vimentin NM_011701 forward primer: 59- AGAGAGAGGAAGCCGAAAGC-39
reverse primer: 59- TCCACTTTCCGTTCAAGGTC-39
E-cadherin NM_009864 forward primer: 59- GAGGTCTACACCTTCCCGGT-39
reverse primer: 59- CCACTTTGAATCGGGAGTCT-39
Mmp7 NM_010810 forward primer: 59- CACATCAGTGGGAACAGGC-39
reverse primer: 59- AGTTTTCCAGTCATGGGCAG-39
Hsp47 NM_009825 forward primer: 59- AACTGTCACTTGCCTGGGTT-39
reverse primer: 59- TAAGGTGCCCAGAAGGAGAG-39
Fsp12/Ctgf NM_010217 forward primer: 59- AGCTGACCTGGAGGAAAACA-39
reverse primer: 59- CCGCAGAACTTAGCCCTGTA-39
Biglycan NM_007542 forward primer: 59- CTTGCTGCCCTTATCCTCTG-39
reverse primer: 59- GGAAGCATAACAGGGTTGGA-39
Hmgb1 NM_010439 forward primer: 59- TGAGCTCCATAGAGACAGCG-39
reverse primer: 59- AGGATCTCCTTTGCCCATGT-39
Has2 NM_008216 forward primer: 59- ATAAGCGGTCCTCTGGGAAT-39
reverse primer: 59- GTTGGTAAGGTGCCTGTCGT-39
Tlr2 NM_011905 forward primer: 59- CATCACCGGTCAGAAAACAA-39
reverse primer: 59- ACCAAGATCCAGAAGAGCCA-39
Tlr3 NM_126166 forward primer: 59- ATGATACAGGGATTGCACCC-39
reverse primer: 59- ATAGGGACAAAAGTCCCCCA-39
Tlr4 NM_021297 forward primer: 59- TGTTCTTCTCCTGCCTGACA-39
reverse primer: 59- TGTCATCAGGGACTTTGCTG-39
Tlr7 NM_133211 forward primer: 59- GGATGATCCTGGCCTATCTC-39
reverse primer: 59- TGTCTCTTCCGTGTCCACAT-39
Tlr9 NM_031178 forward primer: 59- CAGTTTGTCAGAGGGAGCCT-39
reverse primer: 59- CTGTACCAGGAGGGACAAGG-39
18s RNA NR003278 forward primer: 59- GCAATTATTCCCCATGAACG-39
reverse primer: 59- AGGGCCTCACTAAACCATCC- 39
doi:10.1371/journal.pone.0019204.t001
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whereas the CD45- cells were cultured in Dublecco’s modified
Eagle medium (DMEM). Both media were supplemented with
10% fetal calf serum (FCS) and 1% penicillin-streptomycin
100 U/ml and 100 mg/ml. The renal CD45+ or CD45- cells
were treated with either medium or ultrapure LPS, Pam3Cys
lipopeptide, or CpG-DNA (all Invivogen, San Diego, CA). Total
RNA and cell culture supernatants were harvested after 24 or
hours for real time RT-PCR. For fibroblasts isolation kidneys were
minced, passed through 70 and 30 mm cell strainers, and
incubated in normal cell culture medium at 37uC, 5% CO2 for
one to two hours to deplete monocytes and lymphocytes. The cells
were cultured in DMEM supplemented with 10% FCS and 1%
penicillin-streptomycin 100 U/ml and 100 mg/ml. After several
passages until overgrowing of fibroblasts, positive selection of
fibroblasts was isolated by magnetic cell sorting technique (MACS
separation, Miltenyi, Bergisch-Gladbach, Germany) as previously
described [44]. Cells were stained with primary PE-conjugated
antibody (monoclonal anti-mouse CD90, Clone 30-H12, Acris
Antibodies, Hiddenhausen, Germany) in 100 ml buffer containing
PBS, pH 7.2, 0.5% BSA and 2 mM EDTA at 4uC for 10 min in
the dark. The cells were washed by adding 1–2 ml of buffer and
centrifuged twice. Pellets were resuspended in buffer mixed with
anti-PE microbeads and incubated at 4uC for 15 min in the dark.
The collection of labeled cells was carried out by passing through
MACS LS column. After separation cells were found to be .95%
purity by FACS analysis. The renal fibroblasts were treated with
either medium or various stimuli; Pam3CysSK4, ultrapure LPS
(both Invivogen), CpG-ODN 1668 (TIB Molbiol, Berlin, Ger-
many), and TNF-a (ImmunTools, Firesoythe, Germany. Total
RNA and cell culture supernatants were harvested after 24 or
48 hours for real-time RT-PCR and ELISA, respectively.
RNA preparation and real-time quantitative (TaqMan) RT-
PCR
Reverse transcription and real-time RT-PCR from total renal
or cell RNA was performed as described [28]. SYBR Green Dye
detection system was used for quantitative real-time PCR on a
Light Cycler 480 (Roche, Mannheim, Germany). Gene-specific
primers (300 nM, Metabion, Martinsried, Germany) were used as
listed in table 1. Controls consisting of ddH2O were negative for
target and housekeeper genes.
Statistical analysis
Data were expressed as mean 6 standard error of the mean
(SEM). Data from wild-type and Sigirr-deficient mice were
compared with ANOVA on ranks followed by the Student-
Newman-Keuls test using SigmaStat Software (Jandel Scientific,
Erkrath, Germany). T-test was used for direct comparisons
between wild-type and gene-deficient mice. Data are expressed
as mean values 6 SEM. A p value less than 0.05 indicated
statistical significance.
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